This protocol is judged by an institutional overview board, an unbiased group that critiques any medical trials involving humans. If a study requires a Routine I drug, once the board approves the protocol as moral, the researchers must apply for an investigational new drug (IND) variety with the FDA.He claimed he appreciated working with the lawyer